Micol Marchetti
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- Extracellular vesicles in disease
- Angiogenesis and VEGF in Cancer
- RNA Interference and Gene Delivery
Papers in
-
- Circular RNAs in diseases 2
- Epigenetics and DNA Methylation 1
- Histone Deacetylase Inhibitors Research 1
-
- Cancer-related molecular mechanisms research 3
- MicroRNA in disease regulation 2
- Co-authors
- Marco Meloni (4 shared papers)Andrea Caporali (4 shared papers)Costanza Emanueli (4 shared papers)Ilaria Floris (3 shared papers)Graciela Sala-Newby (2 shared papers)Kathryn Garner (1 shared paper)M.Saadeh Suleiman (1 shared paper)Paolo Madeddu (1 shared paper)
- Journals
- Molecular Therapy (2 papers)iScience (1 paper)Circulation Research (1 paper)International Journal of Molecular Sciences (1 paper)American Journal of Physiology-Regulatory, Integrative and Comparative Physiology (1 paper)
- Partner nations
- United KingdomGermanyItaly
In The Last Decade
Micol Marchetti
6 papers receiving 394 citations
Peers
Comparison fields: 5 of 50
- Cancer Research 207
- Molecular Biology 260
- Genetics 23
- Cardiology and Cardiovascular Medicine 47
- Biomaterials 23
Countries citing papers authored by Micol Marchetti
This map shows the geographic impact of Micol Marchetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Micol Marchetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Micol Marchetti more than expected).
Fields of papers citing papers by Micol Marchetti
This network shows the impact of papers produced by Micol Marchetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Micol Marchetti. The network helps show where Micol Marchetti may publish in the future.
Co-authors
The 25 scholars most cited alongside Micol Marchetti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 170 | |
| 2 | 2013 | 134 | |
| 3 | 2014 | 58 | |
| 4 | 2020 | 21 | |
| 5 | 2023 | 13 | |
| 6 | 2024 | 1 |
About Micol Marchetti
Micol Marchetti is a scholar working on Molecular Biology, Cancer Research, Surgery, Nephrology and Cardiology and Cardiovascular Medicine, having authored 6 papers that have together received 397 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (3 papers), MicroRNA in disease regulation (2 papers), Circular RNAs in diseases (2 papers), Epigenetics and DNA Methylation (1 paper), Genetic Syndromes and Imprinting (1 paper), Cardiovascular Disease and Adiposity (1 paper), Cardiovascular, Neuropeptides, and Oxidative Stress Research (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Cancer Research (207 citations), Molecular Biology (260 citations), Genetics (23 citations), Cardiology and Cardiovascular Medicine (47 citations) and Biomaterials (23 citations). Micol Marchetti has collaborated with scholars based in United Kingdom, Germany and Italy. Frequent co-authors include Marco Meloni, Andrea Caporali, Costanza Emanueli, Ilaria Floris, Graciela Sala-Newby, Kathryn Garner, M.Saadeh Suleiman, Paolo Madeddu, Gianfranco Pintus and Orazio Fortunato. Their work appears in journals such as Molecular Therapy, iScience, Circulation Research, International Journal of Molecular Sciences and American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.